Remove Bioinformatics Remove Development Remove Gerontology
article thumbnail

AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine

Scienmag

Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases Credit: Insilico Medicine Thursday, 25th of March 2021 (5:00AM EST) — Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for […].

article thumbnail

Insilico Medicine gets $255 million to boost AI-powered R&D, announces a collaboration

Scienmag

Credit: Insilco June 22, 2021, New York / Hong Kong — Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine’s current therapeutic programs into (..)